Company: RDPTF
Filing Date: 2025-09-18
Form Type: 20-F
Source: 0001213900-25-088699
Chunk: 23

Company: Radiopharm Theranostics Ltd
Filing Date: 2025-09-18
Form: 20-F
Item: Item 3
Chunk 23
---
. Moreover, our competitors
may independently develop substantially equivalent proprietary information and may even apply for patent protection in respect of the
same. If successful in obtaining such patent protection, our competitors could limit our use of our trade secrets and/or confidential
know-how.

Intellectual property rights do not address
all potential threats to our competitive advantage.

The degree of future protection
afforded by our intellectual property rights is uncertain because intellectual property rights have limitations, and may not adequately
protect our business, or permit us to maintain our competitive advantage. The following examples are illustrative:

  Others may be able to make products that are similar to ours but that are not covered by our intellectual property rights.  
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  Others may independently develop similar or alternative technologies or otherwise circumvent any of our technologies without infringing our intellectual property rights.  
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  We or any of our collaboration partners might not have been the first to conceive and reduce to practice the inventions covered by the patents or patent applications that we own, license or wil...  

  We or any of our collaboration partners might not have been the first to file patent applications covering certain of the patents or patent applications that we or they own or have obtained a l...  

  It is possible that any pending patent applications that we have filed, or will file, will not lead to issued patents.  

  Issued patents that we own may not provide us with any competitive advantage, or may be held invalid or unenforceable, as a result of legal challenges by our competitors.  
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  Our competitors might conduct research and development activities in countries where we do not have patent rights, or in countries where research and development safe harbor laws exist, and the...  

  Ownership of our patents or patent applications may be challenged by third parties.  
 ───────────────────────────────────────────────────────────────────────────────────────

  The patents of third parties or pending or future applications of third parties, if issued, may have an adverse effect on our business.  
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

We may face difficulties with protecting
our intellectual property in certain jurisdictions, which may diminish the value